Status:
RECRUITING
6-year Follow-up Data After the Berberine Intervention Trial
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Collaborating Sponsors:
Seventh Medical Center of PLA Army General Hospital
Zhongshan Hospital Xiamen University
Conditions:
Colorectal Adenoma
Colorectal Cancer Control and Prevention
Eligibility:
All Genders
Brief Summary
Colorectal cancer (CRC) is a common malignancy of the digestive tract, which constitutes a major public health burden. Almost 90% of CRC cases progress from precursor adenomatous polyps through adenom...
Eligibility Criteria
Inclusion
- participants who completed the previous berberine intervention study (NCT02226185)
Exclusion
- no
Key Trial Info
Start Date :
October 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
891 Patients enrolled
Trial Details
Trial ID
NCT06629051
Start Date
October 4 2024
End Date
December 31 2024
Last Update
October 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital, Shanghai Jiao-Tong University School of Medicine
Shanghai, China, 200127